Nexalin Technology, Inc. (NXL)
NXL Stock Price Chart
Explore Nexalin Technology, Inc. interactive price chart. Choose custom timeframes to analyze NXL price movements and trends.
NXL Company Profile
Discover essential business fundamentals and corporate details for Nexalin Technology, Inc. (NXL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
16 Sept 2022
Employees
6.00
Website
https://www.nexalin.comCEO
Mark White
Description
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
NXL Financial Timeline
Browse a chronological timeline of Nexalin Technology, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 6 Aug 2025
EPS came in at -$0.10 surpassing the estimated -$0.14 by +28.57%, while revenue for the quarter reached $70.59K , beating expectations by +101.68%.
Earnings released on 13 May 2025
EPS came in at -$0.15 falling short of the estimated -$0.10 by -50.00%, while revenue for the quarter reached $41.02K , beating expectations by +0.04%.
Earnings released on 14 Mar 2025
EPS came in at -$0.28 falling short of the estimated -$0.12 by -133.33%, while revenue for the quarter reached $27.18K , missing expectations by -9.40%.
Earnings released on 8 Nov 2024
EPS came in at -$0.23 falling short of the estimated -$0.12 by -91.67%, while revenue for the quarter reached $36.03K , beating expectations by +20.10%.
Earnings released on 8 Aug 2024
EPS came in at -$0.17 , while revenue for the quarter reached $26.84K .
Earnings released on 10 May 2024
EPS came in at -$0.14 , while revenue for the quarter reached $78.67K .
Earnings released on 27 Mar 2024
EPS came in at -$0.10 , while revenue for the quarter reached $20.54K .
Earnings released on 13 Nov 2023
EPS came in at -$0.31 , while revenue for the quarter reached $24.11K .
Earnings released on 10 Aug 2023
EPS came in at -$0.11 , while revenue for the quarter reached $35.54K .
Earnings released on 10 May 2023
EPS came in at -$0.10 , while revenue for the quarter reached $30.56K .
Earnings released on 27 Mar 2023
EPS came in at -$0.11 , while revenue for the quarter reached $38.42K .
Earnings released on 2 Mar 2023
EPS came in at -$0.03 , while revenue for the quarter reached $545.32K .
Earnings released on 30 Jun 2022
EPS came in at -$0.07 , while revenue for the quarter reached $414.29K .
Earnings released on 31 Mar 2022
EPS came in at -$0.06 , while revenue for the quarter reached $323.32K .
Earnings released on 31 Dec 2021
EPS came in at -$0.13 , while revenue for the quarter reached $24.00K .
Earnings released on 30 Sept 2021
EPS came in at -$0.37 , while revenue for the quarter reached $55.97K .
Earnings released on 30 Jun 2021
EPS came in at -$0.32 , while revenue for the quarter reached $29.15K .
Earnings released on 31 Mar 2021
EPS came in at -$0.32 , while revenue for the quarter reached $34.94K .
Earnings released on 31 Dec 2020
EPS came in at -$0.11 , while revenue for the quarter reached $32.50K .
Earnings released on 30 Sept 2020
EPS came in at -$0.22 , while revenue for the quarter reached $36.91K .
NXL Stock Performance
Access detailed NXL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.